Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002362208 | SCV002666110 | uncertain significance | Cardiovascular phenotype | 2020-03-25 | criteria provided, single submitter | clinical testing | The p.E22933A variant (also known as c.68798A>C), located in coding exon 172 of the TTN gene, results from an A to C substitution at nucleotide position 68798. The glutamic acid at codon 22933 is replaced by alanine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |